NSE's market debut places the exchange among India's most valuable listed companies, highlighting its dominant trading position while putting renewed focus on valuations, regulatory risks and the cyclical nature of exchange businesses.

Alternative pipelines, protected shipping corridors and ship-to-ship transfers have prevented a full-scale global oil supply shock, but the increasingly expensive workarounds are exposing fresh risks for producers, refiners and consumers.

Indian equities come under heavy selling pressure as rising US Treasury yields trigger risk-off sentiment; financial stocks lead declines while NSE shares rebound after a modest listing.

₹150.71-crore issue receives strong early demand as brokerages point to vertical integration, healthy margins and capacity expansion, while highlighting exposure to global auto demand, tariffs and currency movements.

Steel stocks gain as domestic prices strengthen, demand improves and raw-material availability supports the outlook; Motilal Oswal says pricing discipline will be critical for margins in H2FY27.

Domestic airlines carried 12.13 million passengers in August, while Air India Group gained market share and IndiGo's share declined; industry traffic remained broadly flat during the first eight months of 2026.

Master the 50-30-20 framework, build an emergency cushion and turn your first pay cheque into the foundation of long-term financial freedom.

Court raises serious concerns over a cancer medicine carrying an MRP of ₹27,000 despite being supplied to retailers at ₹2,700, highlighting the impact of excessive medicine pricing on patients and public healthcare schemes.

More than 600 million people now have access to annual health cover of up to ₹5 lakh, while the scheme has funded over 13 crore hospital admissions worth ₹2 lakh crore.